Clinical Trial Update: Efficacy and Safety of Inhaled AZD1402 Administered for Four Weeks in Adults With Asthma on Medium-to-High Dose Inhaled Corticosteroids [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of inhaled AZD1402 over four weeks in adults with asthma on medium-to-high-dose inhaled corticosteroids; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• AZD1402

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 2 | Status: TERMINATED | Results posted: 2025-08-28